
Associate Professor of Medicine
at Harvard Medical School
Robert A. Gabbay, MD, PhD, FACP is Associate Professor at Harvard Medical School and the Joslin Diabetes Cetner and former Chief Scientific and Medical Officer of the American Diabetes Association (ADA). Throughout his vibrant career he has had many accomplishments as a basic science researcher, developer of patient communication tools, creator of the first broad scale diabetes registry, designer of care management training programs, digital health innovations, and leader of one of the largest primary care transformation efforts in the US around the Patient Centered Medical Home. The reach of his work has been recognized through leadership roles in national and international arenas. Dr. Gabbay has served as visiting professor, keynote speaker, and on organizing committees for global meetings of the ADA, International Diabetes Federation, Endocrine Society, and the Diabetes Technology Society. Along with an extensive peer reviewed publication record, he has appeared in and is frequently quoted by the popular press including the New York Times, CNN, the Washington Post, and NPR. At the ADA, Dr. Gabbay has led many transformational initiatives including guiding the ADA to a deeper focus on primary care through the establishment of the Primary Care Council (comprised of leading primary care organizations in the US) and the ADA Primary Care Alliance of over 2000 primary care practices committed to transform diabetes care to the reinvigoration of the Standards of Care, the expansion of the Diabetes Prevention Program (DPP) through a multi-year $12.5 million CDC initiative, the launch of the Institute of Learning (IOL), establishment of the Leapfrog initiative to recognize quality care hospital systems for people with diabetes, and leading the association with innovation at the ADA Scientific Sessions and with the ADA’s Innovation Challenge.
Areas of Expertise
Got a Question for Robert Gabbay, MD, PhD?
Get in touch using the contact form linked here and we'll get back to you shortly.